Kyowa Kirin (OTCMKTS:KYKOF) Trading 21.2% Higher – Here’s Why

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF)’s share price traded up 21.2% during trading on Monday . The company traded as high as $15.05 and last traded at $15.05. 900 shares traded hands during trading, a decline of 56% from the average session volume of 2,050 shares. The stock had previously closed at $12.42.

Analyst Upgrades and Downgrades

Separately, The Goldman Sachs Group lowered Kyowa Kirin to a “sell” rating in a research note on Tuesday, December 16th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Kyowa Kirin presently has an average rating of “Sell”.

Kyowa Kirin Price Performance

The company has a 50 day simple moving average of $14.14 and a 200-day simple moving average of $15.31.

Kyowa Kirin Company Profile

Kyowa Kirin Co, Ltd. is a global biopharmaceutical company headquartered in Tokyo, Japan, specializing in the research, development and commercialization of innovative therapies. Established through the merger of Kyowa Hakko Kogyo Co, Ltd. and Kirin Pharma Co, Ltd. in 2008, the company operates as part of the Kirin Group and pursues a mission of delivering cutting-edge medicines in areas of high unmet medical need. Its corporate structure supports integrated research and development, manufacturing and worldwide licensing activities.

The company’s therapeutic focus spans oncology, nephrology, immunology and central nervous system disorders.